Search research articles
Contact Us
Filters
Showing results (31-40 of 129) with videos related to
Page
of 13
Sort By:
European Journal of Neurology
|
August 14, 2021
Magnetic resonance imaging findings in focal-onset status epilepticus
Silvana Sarria-Estrada, Estevo Santamarina, Manuel Quintana, et al.
Epilepsy Research
|
October 27, 2017
Long-term retention rates for antiepileptic drugs: A review of long-term extension studies and comparison with brivaracetam
Manuel Toledo, Rebecca Beale, Jennifer S Evans, et al.
Epilepsy & Behavior : E&B
|
March 11, 2026
Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment
José M Serratosa, Antonio Gil-Nagel, Manuel Toledo, et al.
Epilepsy & Behavior : E&B
|
March 29, 2021
Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial
Manuel Toledo, Christian Brandt, Pier Paolo Quarato, et al.
Epilepsy Research
|
July 30, 2022
Reponse of second-line treatment in focal status epilepticus: A tertiary hospital experience
Arnau Llauradó, Daniel Campos, Manuel Quintana, et al.
Acta Neurologica Scandinavica
|
January 8, 2019
Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain
Adam Strzelczyk, Susanne Knake, Reetta Kälviäinen, et al.
Cannabis and Cannabinoid Research
|
May 17, 2021
A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures
Martin J Brodie, Piotr Czapinski, Ladislav Pazdera, et al.
Human Immunology
|
August 26, 2022
HLA molecular study of patients in a public kidney transplant program in Guatemala
Karla Escobar-Castro, Diana Iraiz Hernández-Zaragoza, Adolfo Santizo, et al.
The Lancet. Neurology
|
November 28, 2016
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial
Michel Baulac, Felix Rosenow, Manuel Toledo, et al.
Acta Neurologica Scandinavica
|
August 18, 2020
Epilepsy in time of COVID-19: A survey-based study
Elena Fonseca, Manuel Quintana, Sofía Lallana, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 129) with videos related to
Sort By:
Page
of 13
European Journal of Neurology
|
August 14, 2021
Magnetic resonance imaging findings in focal-onset status epilepticus
Silvana Sarria-Estrada, Estevo Santamarina, Manuel Quintana, et al.
Epilepsy Research
|
October 27, 2017
Long-term retention rates for antiepileptic drugs: A review of long-term extension studies and comparison with brivaracetam
Manuel Toledo, Rebecca Beale, Jennifer S Evans, et al.
Epilepsy & Behavior : E&B
|
March 11, 2026
Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment
José M Serratosa, Antonio Gil-Nagel, Manuel Toledo, et al.
Epilepsy & Behavior : E&B
|
March 29, 2021
Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial
Manuel Toledo, Christian Brandt, Pier Paolo Quarato, et al.
Epilepsy Research
|
July 30, 2022
Reponse of second-line treatment in focal status epilepticus: A tertiary hospital experience
Arnau Llauradó, Daniel Campos, Manuel Quintana, et al.
Acta Neurologica Scandinavica
|
January 8, 2019
Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain
Adam Strzelczyk, Susanne Knake, Reetta Kälviäinen, et al.
Cannabis and Cannabinoid Research
|
May 17, 2021
A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures
Martin J Brodie, Piotr Czapinski, Ladislav Pazdera, et al.
Human Immunology
|
August 26, 2022
HLA molecular study of patients in a public kidney transplant program in Guatemala
Karla Escobar-Castro, Diana Iraiz Hernández-Zaragoza, Adolfo Santizo, et al.
The Lancet. Neurology
|
November 28, 2016
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial
Michel Baulac, Felix Rosenow, Manuel Toledo, et al.
Acta Neurologica Scandinavica
|
August 18, 2020
Epilepsy in time of COVID-19: A survey-based study
Elena Fonseca, Manuel Quintana, Sofía Lallana, et al.
Page
of 13